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Abstract
Background: Leprosy continues to be an important cause of physical disability in endemic countries such as Brazil.
Knowledge of determinants of these events may lead to better control measures and targeted interventions to
mitigate its impact on affected individuals. This study investigated such factors among the most vulnerable portion
of the Brazilian population.
Methods: A large cohort was built from secondary data originated from a national registry of applicants to social
benefit programs, covering the period 2001–2015, including over 114 million individuals. Data were linked to the
leprosy notification system utilizing data from 2007 until 2014. Descriptive and bivariate analyses lead to a
multivariate analysis using a multinomial logistic regression model with cluster-robust standard errors. Associations
were reported as Odds Ratios with their respective 95% confidence intervals.
Results: Among the original cohort members 21,565 new leprosy cases were identified between 2007 and 2014.
Most of the cases (63.1%) had grade zero disability. Grades 1 and 2 represented 21 and 6%, respectively. Factors
associated with increasing odds of grades 1 and 2 disability were age over 15 years old (ORs 2.39 and 1.95,
respectively), less schooling (with a clear dose response effect) and being a multibacillary patient (ORs 3.5 and 8.22).
Protective factors for both grades were being female (ORs 0.81 and 0.61) and living in a high incidence municipality
(ORs 0.85 and 0.67).
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Conclusions: The findings suggest that the developing of physical disabilities remains a public health problem
which increases the burden of leprosy, mainly for those with severe clinical features and worse socioeconomic
conditions. Early diagnosis is paramount to decrease the incidence of leprosy-related disability and our study points
to the need for strengthening control actions in non-endemic areas in Brazil, where cases may be missed when
presented at early stages in disease. Both actions are needed, to benefit patients and to achieve the WHO goal in
reducing physical disabilities among new cases of leprosy.
Keywords: Physical disabilities, Leprosy, Socioeconomic factor, Brazil
Background
Chronic infections with Mycobacterium leprae have the
potential to cause lasting nerve damage and physical dis-
abilities [1, 2]. Among patients with leprosy, physical dis-
abilities arise as a result of late diagnosis and/or
insufficient treatments. The incidence of leprosy-related
disabilities among newly detected cases is, therefore, an
important indicator of gaps in population-level leprosy
control strategies. Leprosy cases are classified as: Grade
0 disability (G0D), when muscle strength and sensitivity
of these segments are preserved; Grade 1 (G1D), when
there are decreased muscle strength and/or decreased
sensitivity; and Grade 2 (G2D), when there are visible
deformities in the hands, feet, and/or eyes [3, 4].
As part of the 2016–2020 Global Leprosy Strategy, the
World Health Organization (WHO) has set a target of
reducing the rate of newly diagnosed leprosy patients
with G2D to less than 1 per million population [4]. In
Brazil, a country with a high leprosy new case detection
rate (13.7/100,000 population in 2018), the National
Leprosy Disease Program has similarly prioritized redu-
cing the rate of diagnosis with G2D as a primary goal.
From 2012 to 2016, the mean rate of leprosy new case
detection with G2D in Brazil was 10.5 per 1 million in-
habitants, with an average of 2042 people diagnosed an-
nually with leprosy-related G2D in this period [5]. In the
last decades, Brazil has adopted extensive public health
measures to improve the assessment and prevention of
leprosy-related physical disabilities [6]. Nevertheless, a
systematic review conducted by Vieira et al. (2018) [7],
indicates that the proportion of leprosy cases presenting
disability among children < 15 years remains high in
Brazil, reflecting active transmission and challenges for
case detection.
Although there have been large-scale studies in Brazil
studying the social determinants of leprosy incidence
and treatment default [8, 9], risk factors for leprosy-
associated disability at the time of diagnosis remain
scarcely investigated. In Brazil, there are problems re-
lated to underdiagnosis and underreporting of new cases
of leprosy, which have had a major impact on the ability
to plan control activities for the disease. In addition, pri-
mary health services face difficulties in monitoring
patients after completing treatment and monitoring dis-
abilities. Using nationwide linked data from the 100 Mil-
lion Brazilian Cohort, this study used large-scale data to
identify risk factors for having leprosy-related physical
disabilities at the time of diagnosis.
Methods
Study design and data source
The 100 Million Brazilian Cohort [10, 11] was built by
linking health and administrative records of individuals
registered in the Cadastro Único para Programas Sociais
(CadÚnico), a national registry for social assistance pro-
grams in the country. This database was created at the
Centro de Integração de Dados e Conhecimentos para
Saúde at Oswaldo Cruz Foundation (Cidacs, Salvador,
Bahia, Brazil) and is part of the Center’s mission to
evaluate the impact of social determinants and policies
on health. The cohort includes administrative records
from over 114 million individuals who applied for social
assistance between 2001 and 2015.
As previously described [8, 9, 12, 13] the data from the
100 Million Brazilian Cohort was then linked to leprosy
notification records in the national notifiable disease sys-
tem, Sistema de Informação de Agravos de Notificação,
SINAN-leprosy.
Settings and participants
The study population for this investigation included
members of the 100 Million Brazilian Cohort followed
from January 1st 2007 until December 31st 2014. Cohort
members were excluded if they: (i) were diagnosed with
leprosy prior to registration in CadÚnico, (ii) belonged
to family units with no member aged over 15 years (i.e.,
children registered separately from their families), (iii)
had less than 1 day of follow-up, (iv) were relapsed lep-
rosy cases or (v) did not have information on grade of
disability at diagnosis.
Outcome and exposures
For this study, the primary outcome was the detection of
physical disabilities caused by leprosy, classified as grade
0 (G0D), grade 1 (G1D) or grade 2 (G2D).
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Exposure variables were related to individual socioeco-
nomic indicators (i.e., sex, age, self-identified race/ethni-
city, literacy, schooling, and employment status) and
household living conditions (i.e., household density,
housing materials, water source, electricity source, sew-
age disposal, and waste disposal). For individuals under
18 years old, education and employment were reported
as the education level and employment status of the
head of the family (here defined as the oldest member of
the family).
Geographic exposures included Brazilian region of
residence, urbanicity (urban or rural), and residence in a
‘high-burden cluster’. The definition of clusters of higher
incidence was the one used by Penna et al. (2009) [14],
based on epidemiological data of Brazil from 1980 until
2007. These clusters were defined as 29 spatial clusters
comprising 789 municipalities and were devised to facili-
tate decision-making for leprosy control across the
country. Although these were defined more than 10 years
ago, a recent study [15] analyzed the spatial distribution
of leprosy in selected endemic regions of the country
comparing the periods 2001–2003 versus 2010–2012
and concluded that there is significant overlap of clus-
ters comparing both time periods.
Clinical exposures included the operational classifica-
tion of leprosy (i.e., paucibacillary or multibacillary [PB
or MB]) and the number of skin lesions.
Statistical analysis
Descriptive analysis was performed to assess the distri-
bution of the independent variables, followed by bivari-
ate analysis with the outcome (presence of any degree of
disability) to assess the strength of association between
independent variables and grade of disability at diagno-
sis. Those with a p-value less than 0.1 were considered
eligible for the multivariate model.
For the multivariate analysis, a multinomial logistic re-
gression model with cluster-robust standard errors (i.e.,
accounting for familial clustering of covariates) to esti-
mate the adjusted odds ratios (OR) was used, with grade
zero disability cases used as the reference category. The
adjusted ORs will therefore represent the odds of the
outcome (G1D or G2D versus grade zero) associated
with that particular category of the independent variable
compared to the reference category for the same
variable.
All analyses were performed using Stata, version 15.0
(Stata Corp LLC, College Station, Texas, USA).
Ethics
This study was performed under the international
(Helsinki), Brazilian and United Kingdom research regu-
lations and was approved by three Ethics Committees of
Research: (i) University of Brasília (1.822.125), (ii)
Instituto Gonçalo Muniz – Fiocruz (1.612.302) and (iii)
London School of Hygiene and Tropical Medicine’s Re-
search Committee (10580–1).
Role of funding source
This study was funded by The Medical Research Council
(MR/N017250/1), Conselho Nacional das Fundações
Estaduais de Amparo à Pesquisa / Economic and Social
Research Council / Medical Research Council / Biotech-
nology and Biological Sciences Research Council / Con-
selho Nacional de Desenvolvimento Científico e
Tecnológico / Fundação de Apoio à Pesquisa do Distrito
Federal (CONFAP/ESRC/MRC/BBSRC/CNPq/FAPDF)
– Doenças Negligenciadas, (Number 193.000.008/2016),
and the Wellcome Trust (202.912/B/16/Z). The funders
of the study had no role in the design, data collection,
analysis, interpretation, or writing the article.
Results
The study population included 21,565 new leprosy cases
detected in Brazil between 2007 to 2014 (Fig. 1). At the
time of diagnosis, 15,095 (63.1%) cases had G0D, while
grades 1 and 2 represented 21% (5026) and 6% (1444),
respectively. In the multivariate model, 16,376 cases
were included, as missing values for some variables pre-
vented a number of cases from being included.
Newly detected leprosy cases had a mean age of 37.6
years old (SD 19.5), varying by the grade of disability
(G0D 34.9; G1D 43.4; G2D 45.7) (Table 1). Overall,
49.6% of the leprosy cases were female, 72.1% was iden-
tified as mixed race (“pardo”), 79.3% were literate and
60.7% had up to 5 years of education, and 50.9% were
unemployed or unemployed but currently studying. Al-
though 81.8% earned up to 0.5 minimum wage, 11.3%
reported no source of income. Most of the leprosy cases
lived in urban areas (79.5%) and in the Northeast
(40.4%) and the North (23.6%) regions. The greater pro-
portion of the cases lived in municipalities that belonged
to the epidemiologically-defined high incidence clusters
(63.8%). Also, 69.3% of the cases lived in brick or
cement-made dwellings, with publicly provided water,
garbage collection and electricity. However, 67% of them
reported using a homemade tank as a sewage disposal
system. There were more MB cases than PB (59.2% vs
40.8%) at time of diagnosis (Table 1).
In multivariate analysis, the odds of G1D were higher
among leprosy cases aged over 15 years (OR 2.39; 95%CI
2.06–2.77), as well as among those with lower levels of
education – no education/pre-school (OR 1.64; 95%CI
1.40–1.93), 1–5 years of education (OR 1.48; 95%CI
1.28–1.70), and 6–9 years of education (OR 1.28; 95%CI
1.10–1.48), unemployed (OR 1.19; 95%CI 1.06–1.32) and
living in rural areas (OR 1.14; 95%CI 1.04–1.26)
(Table 2). Cases with MB leprosy (OR 3.50; 95%CI 3.13–
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3.92) and with lesions (OR 1.12; 95%CI 1.02–1.24) were
also more likely to have G1D. Factors that showed to be
protective against G1D included being female (OR 0.81;
95%CI 0.75–0.88), increased household density (> 1
inhab/romm – OR 0.79; 95%CI 0.71–0.88) and living in
a high-incidence cluster municipality (OR 0.85; 95%CI
0.78–0.93) (Table 2).
For G2D, the model showed similar risk factors to the
G1D analysis (Table 2). Both age above 15 years old (OR
1.95; 95%CI 1.51–2.50) and lower levels of education
Fig. 1 Study population selection flowchart from the 100 Million Brazilian Cohort
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Table 1 Characteristics of leprosy cases evaluated for physical disabilities. The 100 Million Brazilian Cohort, 2007–2014
Variables Physical Disabilities Total
Grade 0 Grade 1 Grade 2
(N = 15,095) (N = 5,026) (N = 1,444)
n(%) n(%) n(%) n(%)
Individual characteristics
Age (Mean [SD]) 34.9 (19.2) 43.4 (18.6) 45.7 (19.0) 37.6 (19.5)
Sex
Male 6,984 (46.3) 2,915 (58.0) 965 (66.8) 10,864 (50.4)
Female 8,111 (53.7) 2,111 (42.0) 479 (33.2) 10,701 (49.6)
Ethnicity
White 2,645 (17.9) 1,076 (21.8) 330 (23.2) 4,051 (19.2)
Black 1,178 (8.0) 412 (8.4) 132 (9.3) 1,722 (8.1)
Asian 49 (0.3) 19 (0.4) 1 (0.1) 69 (0.3)
Mixed (brown) 10,879 (73.5) 3,406 (69.0) 956 (67.3) 15,241 (72.1)
Indigenous 48 (0.3) 20 (0.4) 1 (0.1) 69 (0.3)
Ignored/Missing 455 (0.02)a
Literacy
Yes 12,182 (81.5) 3,714 (74.6) 1,028 (71.6) 16,924 (79.3)
No 2,760 (18.5) 1,262 (25.4) 407 (28.4) 4,429 (20.7)
Ignored/Missing 234 (0.01)a
Schooling
No education/Pre-school 2,266 (17.0) 1,060 (23.3) 362 (26.8) 3,688 (19.2)
Primary School (1–5 years) 5,346 (40.1) 2,034 (44.6) 595 (44.1) 7,975 (41.5)
High School (6–9 years) 3,981 (29.9) 1,101 (24.1) 302 (22.4) 5,384 (28.0)
Senior High School (10–12 years) 1,677 (12.6) 350 (7.7) 89 (6.6) 2,116 (11.0)
Higher Education (≥12 years) 48 (0.4) 14 (0.3) 2 (0.2) 64 (0.3)
Ignored/Missing 2,566 (0.1)a
Work condition
Employed 6,801 (50.6) 2,073 (46.1) 562 (44.2) 9,436 (49.1)
Unemployed 3,211 (23.9) 1,309 (29.1) 421 (33.1) 4,941 (25.7)
Unemployed but currently studying 3,434 (25.5) 1,112 (24.8) 288 (22.7) 4,834 (25.2)
Ignored/Missing 2,615 (0.1)a
Per capita income
No income 1,682 (11.1) 577 (11.5) 173 (12.0) 2,432 (11.3)
0–0.25 minimum wage 8,580 (56.8) 2,428 (48.3) 681 (47.2) 11,689 (54.2)
0.25–0.5 minimum wage 2,440 (16.2) 835 (16.6) 241 (16.7) 3,516 (16.3)
0.5–1 minimum wage 1,910 (12.7) 961 (19.1) 285 (19.7) 3,156 (14.6)




North 3,636 (24.1) 1,164 (23.2) 298 (20.6) 5,098 (23.6)
Northeast 6,401 (42.4) 1,822 (36.2) 497 (34.4) 8,720 (40.4)
Southeast 1,966 (13.2) 814 (16.2) 297 (20.6) 3,107 (14.4)
South 346 (2.3) 202 (4.0) 88 (6.1) 636 (3.0)
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Table 1 Characteristics of leprosy cases evaluated for physical disabilities. The 100 Million Brazilian Cohort, 2007–2014 (Continued)
Variables Physical Disabilities Total
Grade 0 Grade 1 Grade 2
(N = 15,095) (N = 5,026) (N = 1,444)
n(%) n(%) n(%) n(%)
Midwest 2,716 (18.0) 1,024 (20.4) 264 (18.3) 4,004 (18.6)
Area of residence
Urban 12,100 (80.2) 3,894 (77.6) 1,128 (78.3) 17,122 (79.5)
Rural 2,984 (19.8) 1,125 (22.4) 312 (21.7) 4,421 (20.5)
Ignored/Missing 22 (0.0)a
Household density
≤ 0.5 inhab/room 5,014 (33.7) 2,141 (43.2) 619 (43.7) 7,774 (36.6)
0.5–0.75 inhab/room 2,802 (18.8) 848 (17.1) 230 (16.2) 3,880 (18.2)
0.75–1.00 inhab/room 3,320 (22.3) 970 (19.6) 253 (17.8) 4,543 (21.4)
> 1.00 inhab/room 3,754 (25.2) 995 (20.1) 316 (22.3) 5,065 (23.8)
Ignored/Missing 338 (0.01)
Construction material
Bricks/Cement 10,429 (70.0) 3,347 (67.5) 975 (68.7) 14,751 (69.3)
Wood/Taipa/Others 4,473 (30.0) 1,610 (32.5) 444 (31.3) 6,527 (30.7)
Ignored/Missing 318 (0.01)a
Water supply
Public network (tap water) 10,171 (68.3) 3,311 (66.8) 978 (68.9) 14,460 (68.0)
Well/Natural source/Others 4,731 (31.7) 1,646 (33.2) 441 (31.1) 6,818 (32.0)
Ignored/Missing 318 (0.01)a
Electricity
Electricity with counter 13,566 (91.0) 4,468 (90.1) 1,278 (90.1) 19,312 (90.8)
Electricity without counter 1,336 (9.0) 489 (9.9) 141 (9.9) 1,966 (9.2)
Ignored/Missing 318 (0.01)a
Waste disposal system
Public network/Septic tank 4,823 (32.8) 1,588 (32.6) 506 (36.5) 6,917 (33.0)
Homemade tank/Ditch/Others 9,864 (67.2) 3,285 (67.4) 879 (63.5) 14,028 (67.0)
Ignored/Missing 705 (0.03)a
Garbage disposal
Public collection system 11,409 (76.6) 3,654 (73.7) 1,070 (75.4) 16,133 (75.8)
Burned/Buried/Outdoor disposal/Others 3,494 (23.4) 1,303 (26.3) 349 (24.6) 5,146 (24.2)
Ignored/Missing 317 (0.01)a
High-burden cluster municipality
No 5,148 (34.1) 1,987 (39.5) 679 (47.0) 7,814 (36.2)
Yes 9,947 (65.9) 3,039 (60.5) 765 (53.0) 13,751 (63.8)
Clinical characteristics
WHO operational classification
Paucibacillary 7,698 (51.0) 968 (19.3) 128 (8.9) 8,794 (40.8)
Multibacillary 7,396 (49.0) 4,058 (80.7) 1,316 (91.1) 12,770 (59.2)
Ignored/Missing 3 (0.0)a
Presence of lesions
No 9,123 (60.4) 1,862 (37.0) 432 (29.9) 12,419 (51.9)
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appeared to influence the odds of had G2D, specifically,
no education/pre school (OR 1.91; 95%CI 1.44–2.53)
and 1–5 years of education (OR 1.64; 95%CI 1.27–2.12).
Being a MB leprosy case was also a risk factor (OR 8.22;
95%CI 6.51–10.38) to have G2D. However, being female
(OR 0.61; 95%CI 0.53–0.70) and living in a high-
incidence cluster municipality (OR 0.67; 95%CI 0.58–
0.78) decreased the odds of presenting G2D at diagnosis.
Protective effects were also observed for living in the
North (OR 0.53; 95%CI 0.39–0.72), Northeast (OR 0.53;
95%CI 0.39–0.71) and Midwest regions (OR 0.50; 95%CI
0.36–0.68) (Table 2).
Discussion
This study investigated factors associated with leprosy-
related disability in a large Brazilian patient population
of 21,565 new leprosy cases. Our results showed lower
odds of having grade 1 or grade 2 physical disabilities as-
sociated with being a woman, living in the North, North-
east and Midwest regions or in high-incidence clusters,
in urban areas, and increased household crowding. How-
ever, new leprosy cases aged over 15 years, with a lower
levels of education, unemployed and with multibacillary
leprosy had higher chances of presenting grade 1 or
grade 2 physical disabilities at diagnosis.
The higher likelihood of leprosy-related disabilities
found among those older than 15 years is similar to pre-
vious studies. In a hyperendemic area of the Midwest re-
gion of Brazil, the estimated risk ratio of G2D was 5.3
times higher among patients aged ≥45 years [16]. In the
state of Minas Gerais, a retrospective study showed that
age above 15 years was an important risk factor for the
development of physical disability in leprosy patients as
well [17]. A study of patients from the state of Maranhão
showed a progressive increase in the chances of develop-
ing physical disability among those older than 15 years,
ranging from 3 to 10.4 times higher risk [18]. Consider-
ing that the duration of the disease is directly related to
age and, given the chronic nature of the disease, increas-
ing age may result in more advanced disabilities [17, 19].
Regarding gender, some studies did not identify an as-
sociation between gender and level of disability [20–22].
However, other studies reported higher grades of phys-
ical disability among male individuals with leprosy [17,
23]. Men are generally more exposed to M. leprae and
have reduced contact with health care, which may delay
diagnosis and increases the risk of developing physical
disabilities [24]. For the general population in Brazil, be-
tween 2012 and 2016, the detection rate of new cases
with physical disability grade 2 was higher in males. This
rate was 15.2 and 6.1 cases per 1 million among men
and women, respectively [5]. Cultural factors may ex-
plain the difference by gender as women may be more
likely to seek health care [18].
Our study also suggests that higher levels of education
were negatively associated with the presence of physical
disabilities at diagnosis, which is consistent with the lit-
erature [16, 17]. Higher education has been shown to be
associated with better understanding of the disease and,
consequently, better access and utilization of health ser-
vices. Regular treatment and evaluation, as well as self-
care, are aspects that may prevent the worsening of clin-
ical manifestations [17, 25].
The fact that cases from the Northeast and the North
regions were less likely to present G2D contrasts with
the findings from Freitas and colleagues (2014) [26],
which showed greater proportions of G2D in municipal-
ities with higher incidence rates of leprosy. In their
work, the explanation presented for this fact was that
better surveillance was leading to a higher detection rate.
And subsequently, this was leading to more G2D cases
that were found by contact tracing. However, the areas
with higher endemicity, in general, do not have a better
structured surveillance and care system, as they are sys-
tematically poorer. The clusters are located in more vul-
nerable areas.
Therefore, this fact is likely due to a more sensitive
health staff and surveillance system to case detection,
therefore more capable of detecting leprosy cases earlier.
Assuming that disability is a marker for late diagnosis, it
is expected that regions of high endemicity will show a
lower chance of patients presenting with grades 1 and 2
disability. G2D, as already mentioned, may indicate late
diagnosis and a suboptimal surveillance system. Accord-
ing to Penna et al. (2009) [14], access to primary health
care units has improved mainly in rural areas and small
towns, improving the diagnosis of leprosy in the first
decade of this century. Also, as her work emphasizes,
Table 1 Characteristics of leprosy cases evaluated for physical disabilities. The 100 Million Brazilian Cohort, 2007–2014 (Continued)
Variables Physical Disabilities Total
Grade 0 Grade 1 Grade 2
(N = 15,095) (N = 5,026) (N = 1,444)
n(%) n(%) n(%) n(%)
Yes 5,940 (39.4) 3,135 (62.4) 1,004 (69.5) 11,419 (47.8)
Ignored/Missing 32 (0.2) 29 (0.6) 8 (0.6) 73 (0.3)a
aThe percentage of ignored/missing data refers a part of the total
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Table 2 Univariate and adjusted analyses for grade of physical disabilities. The 100 Million Brazilian Cohort, 2007–2014













(N = 5,026) (N = 5,026) (N = 1,444) (N = 1,444)
Individual characteristics
Age
Up to 15 years old 1.00 1.00 1.00 1.00
> 15 years old 3.41 (3.01–3.87) 2.39 (2.06–2.77) 3.28 (2.63–4.11) 1.95 (1.51–2.50)
Sex
Male 1.00 1.00 1.00 1.00
Female 0.62 (0.58–0.66) 0.81 (0.75–0.88) 0.48 (0.38–0.48) 0.61 (0.53–0.70)
Schooling
No education/Pre-school 1.60 (0.86–2.94) 1.64 (1.40–1.93) 3.83 (0.93–15.88) 1.91 (1.44–2.53)
Primary School (1–5 years) 1.30 (0.71–2.38) 1.48 (1.28–1.70) 2.67 (0.65–11.04) 1.64 (1.27–2.12)
High School (6–9 years) 0.95 (0.52–1.74) 1.28 (1.10–1.48) 1.82 (0.44–7.55) 1.31 (1.00–1.72)
Senior High School (10–12 years) 0.72 (0.39–1.32) – 1.27 (0.30–5.34) –
Higher Education (≥12 years) 1.00 1.00 1.00 1.00
Work condition
Employed 1.00 1.00 1.00 1.00
Unemployed 1.06 (0.98–1.16) 1.19 (1.06–1.32) 1.01 (0.86–1.18) 1.47 (1.23–1.74)
Unemployed but currently studying 1.34 (1.23–1.45) 1.13 (1.03–1.24) 1.59 (1.39–1.81) 1.15 (0.98–1.35)
Household characteristics
Region of residence
North 0.55 (0.46–0.66) 0.91 (0.72–1.15) 0.32 (0.25–0.42) 0.53 (0.39–0.72)
Northeast 0.49 (0.41–0.58) 0.81 (0.64–1.01) 0.31 (0.24–0.39) 0.53 (0.39–0.71)
Southeast 0.70 (0.58–0.85) 1.06 (0.84–1.33) 0.58 (0.45–0.76) 0.80 (0.59–1.08)
South 1.00 1.00 1.00 1.00
Midwest 0.65 (0.54–0.78) 0.86 (0.68–1.09) 0.38 (0.29–0.49) 0.50 (0.36–0.68)
Area of residence
Urban 1.00 1.00 1.00 1.00
Rural 1.17 (1.08–1.27) 1.14 (1.04–1.26) 1.12 (0.98–1.28) 1.05 (0.89–1.24)
Household density
≤ 0.5 inhab/room 1.00 1.00 1.00 1.00
0.5–0.75 inhab/room 0.71 (0.65–0.78) 0.87 (0.78–0.98) 0.66 (0.57–0.78) 0.96 (0.80–1.16)
0.75–1.00 inhab/room 0.68 (0.63–0.75) 0.87 (0.78–0.97) 0.62 (0.53–072) 0.85 (0.71–1.03)
> 1.00 inhab/room 0.62 (0.57–0.68) 0.79 (0.71–0.88) 0.68 (0.59–0.79) 1.04 (0.87–1.23)
High-burden cluster municipality
No 1.00 1.00 1.00 1.00
Yes 0.79 (0.74–0.85) 0.85 (0.78–0.93) 0.58 (0.52–0.65) 0.67 (0.58–0.78)
Clinical characteristics
WHO operational classification
Paucibacillary 1.00 1.00 1.00 1.00
Multibacillary 4.36 (4.04–4.71) 3.50 (3.13–3.92) 10.70 (8.90–12.87) 8.22 (6.51–10.38)
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there is a cultural component related to the presence of
skin lesions in populations that are used to seeing this
type of clinical manifestation of the disease (i.e., in highly
endemic areas), coupled with health-seeking behavior
among these individuals.
The study by Freitas et al. (2014) [26] looked at risk fac-
tors and identified a high new case detection rate in the
Midwest and North regions compared to the South, large
cities and greater urbanization, median and high illiteracy
rate, income inequality (Gini index), hosehold’ crowding,
worse sanitation condition, and percentage of cases with
grade 2 disability. Differences between these findings and
our results may stem from the fact that our study focused
on G2D at diagnosis, which does not necessarily mirror
risk factors for higher incidence or new case detection
rate. As we are hypothesizing, high incidence and detec-
tion of disabilities may be influenced by different factors.
It is technically difficult to separate short- and long-term
effects of increased surveillance [8].
The association between the proportion of multibacil-
lary leprosy and presentation of G2D has been shown in
the past [16, 27, 28]. Studies conducted in some Brazil-
ian municipalities indicate that at the time of diagnosis,
educational level and operational classification are statis-
tically associated with the development of physical dis-
abilities. It is emphasized that multibacillary patients are
twice more likely to develop sequelae than paucibacillary
patients [29].
Our study has several strengths. Although there are
studies addressing leprosy related disabilities, (i) our
large sample size and extensive follow up period
allowed us to evaluate determinants of leprosy-related
physical disabilities to an extent that is rarely pos-
sible; (ii) this study linked data from over 100 million
individuals and was able to assess factors associated
with physical disability in an unprecedented way; (iii)
additionally, using administrative databases linkage we
also were able to evaluate a wider range of variables
available in CadÚnico and; (iv) unlike other studies,
we analyzed the most vulnerable fraction of the Bra-
zilian population, for whom biological and poverty-
related risk factors for leprosy overlap.
Nevertheless, our study has some limitations. The use of
secondary data originated from routine surveillance activ-
ities always brings the issue of completeness of informa-
tion. We did not have complete information on disability
evaluation at diagnosis (n = 1557) and at discharge. The
latter was poorly collected to an extent that did not allow
us to use that timepoint in the analysis. Efforts should be
undertaken to stress the importance of performing this
evaluation at discharge and record it in the information
systems. Other factors associated with disability were not
available in our database and therefore, could not be
assessed, such as health services characteristics and pa-
tients’ perception and knowledge about leprosy. In
addition, although there is biological plausibility and refer-
ences showing the association between leprosy reactions
and presentation of disability [25, 27], this information
was not obtained in our study population at time of diag-
nosis. Reactions are reported in the system only when the
episode happens during the course of treatment, and this
precludes us from assessing this topic in our study.
Conclusion
The findings suggest that the development of leprosy-
related physical disabilities remains a public health prob-
lem, mainly for those with severe clinical features and
worse socioeconomic conditions. Early diagnosis is para-
mount to decrease the incidence of disabilities and focus
should be given to younger patients, considering these
individuals are of working age. Our study points to the
need for strengthening control actions in non-endemic
areas in Brazil, where cases may be missed when pre-
sented at early stages in the course of infection. Besides,
social protection policies and initiatives are key to lead
us to effective leprosy control – evidence that has been
put forth a century ago [30] and yet remains valid. Fu-
ture research should study disability-related socioeco-
nomic and clinical factors at the end of treatment and
explore if the findings from this work will hold among
relapses or reinfections.
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